Welcome to our daily roundup of top insider trades. Here’s a look at the most significant inside purchases recently filed with the SEC.Notable Purchases:
The global health-care group GlaxoSmithKline (NYSE:GSK) bought 342,229 shares of biopharmaceutical company Theravance (NASDAQ:THRX) for $12,850,699.
The Japanese trading company Marubeni (OTCMKTS:MARUY) bought 60,000 shares of high-utility commercial jet aircraft company Aircastle (NYSE:AYR) for $1,100,166.
Nancy Schoendorf, a director […]